SPOTLIGHT: Biotech start-up begins building

BioConvergence, a start-up biotech company, is preparing to break ground on a $14 million facility in Bloomington, Indiana, and create 170 jobs over the next five years. Article

Suggested Articles

Robertson, M.D., who led global development teams within Shire’s neuroscience division, is now Yumanity Therapeutics’ chief medical officer.

Novo Nordisk and Dicerna are teaming up on liver-related diseases, including nonalcoholic steatohepatitis (NASH), to the tune of $225 million.

After announcing it was slashing scores of jobs, Alkermes is now willing to put down nearly $1 billion to buy out CNS biotech Rodin Therapeutics.